Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,643 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Local anesthetics elicit immune-dependent anticancer effects.
Bezu L, Wu Chuang A, Sauvat A, Humeau J, Xie W, Cerrato G, Liu P, Zhao L, Zhang S, Le Naour J, Pol J, van Endert P, Kepp O, Barlesi F, Kroemer G. Bezu L, et al. Among authors: kroemer g. J Immunother Cancer. 2022 Apr;10(4):e004151. doi: 10.1136/jitc-2021-004151. J Immunother Cancer. 2022. PMID: 35483744 Free PMC article.
Ecto-calreticulin in immunogenic chemotherapy.
Obeid M, Tesniere A, Panaretakis T, Tufi R, Joza N, van Endert P, Ghiringhelli F, Apetoh L, Chaput N, Flament C, Ullrich E, de Botton S, Zitvogel L, Kroemer G. Obeid M, et al. Among authors: kroemer g. Immunol Rev. 2007 Dec;220:22-34. doi: 10.1111/j.1600-065X.2007.00567.x. Immunol Rev. 2007. PMID: 17979837 Review.
Molecular characteristics of immunogenic cancer cell death.
Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G. Tesniere A, et al. Among authors: kroemer g. Cell Death Differ. 2008 Jan;15(1):3-12. doi: 10.1038/sj.cdd.4402269. Epub 2007 Nov 16. Cell Death Differ. 2008. PMID: 18007663 Review.
To die or not to die: that is the autophagic question.
Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiuri MC, Kroemer G. Galluzzi L, et al. Among authors: kroemer g. Curr Mol Med. 2008 Mar;8(2):78-91. doi: 10.2174/156652408783769616. Curr Mol Med. 2008. PMID: 18336289 Review.
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.
Panaretakis T, Joza N, Modjtahedi N, Tesniere A, Vitale I, Durchschlag M, Fimia GM, Kepp O, Piacentini M, Froehlich KU, van Endert P, Zitvogel L, Madeo F, Kroemer G. Panaretakis T, et al. Among authors: kroemer g. Cell Death Differ. 2008 Sep;15(9):1499-509. doi: 10.1038/cdd.2008.67. Epub 2008 May 9. Cell Death Differ. 2008. PMID: 18464797
Immunogenic cancer cell death: a key-lock paradigm.
Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, Schlemmer F, Zitvogel L, Kroemer G. Tesniere A, et al. Among authors: kroemer g. Curr Opin Immunol. 2008 Oct;20(5):504-11. doi: 10.1016/j.coi.2008.05.007. Epub 2008 Jun 23. Curr Opin Immunol. 2008. PMID: 18573340 Review.
Targeting p53 to mitochondria for cancer therapy.
Galluzzi L, Morselli E, Kepp O, Tajeddine N, Kroemer G. Galluzzi L, et al. Among authors: kroemer g. Cell Cycle. 2008 Jul 1;7(13):1949-55. doi: 10.4161/cc.7.13.6222. Cell Cycle. 2008. PMID: 18642442 Review.
1,643 results